Latha Palaniappan Selected as Fulbright Scholar for Research in Precision Health

As a recently selected Fulbright U.S. Scholar for the 2022-2023 academic year, Latha Palaniappan MD, MS, will travel to Australia to expand her research in precision health.

Fulbright Scholar Awards are esteemed fellowships that involve a rigorous application process and provide a unique opportunity for scholars to teach or conduct research abroad. Former recipients include numerous Nobel Laureates, Pulitzer Prize winners, MacArthur Fellows and other world-renowned experts. The program benefits the individual recipient by promoting cross-cultural communication skills and opening doors to greater international co-publication. With this award, Palaniappan will also further Stanford University’s connections with researchers, potential students and alumni around the globe.

Palaniappan is an internist and clinical researcher focused on the study of diverse populations, chronic disease and prevention. She piloted the first pharmacogenomics clinic at Stanford University and serves on the editorial board for the Journal of Personalized Medicine.

The Fulbright award builds upon Palaniappan’s previous accomplishments by supporting her interest in the implementation of pharmacogenomics in health systems around the world. In Australia, she will partner with the Commonwealth Scientific and Industrial Research Organization (CSIRO) to explore pharmacogenomic testing in a universal health care system. This effort, she says, is crucial to strengthening global health. “It is vital to incorporate precision health into our everyday clinical interactions in order to improve health outcomes for all populations,” she explains.

We wish her the best as she heads overseas in her mission to advance precision medicine!